Zykadia
Ceritinib
- Strength
- 150mg
- Manufacturer
- Novartis Pharma
- Availability
- Available to source
Ceritinib 150mg — Capsule, 150's Strip
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
About this medicine
Originator: Zykadia by Novartis Pharmaceuticals · Manufacturer: Novartis Pharma. Indication & Dosage: Zykadia (Ceritinib), is a prescription medicine used to treat anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) for which patients who are unable to tolerate or have progressed on prior crizotinib therapy. Zykadia Manufactured by Novartis Pharma Ltd. in Switzerland. Ceritinib has to take 450 mg orally once daily with food. *First dose reduction: 300 mg qDay *Second dose reduction: 150 mg qDay *Unable to tolerate 150 mg/ day: Discontinue Side Effects: The most common adverse reactions of Ceritinib are: Diarrhea , nausea , vomiting , abdominal pain, loss of appetite , heartburn, constipation, or tiredness. The above information comes from the Internet. Please consult with doctor for medical advice.
Indications
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.
